| Literature DB >> 31707764 |
Cornelia Cato Ter Haar1,2, Ron J G Peters1, Jan Bosch3, Agnese Sbrollini4, Sophia Gripenstedt1, Rob Adams1, Eduard Bleijenberg5, Charles J H J Kirchhof6, Reza Alizadeh Dehnavi2,7, Laura Burattini4, Robbert J de Winter1, Peter W Macfarlane8, Pieter G Postema1, Sumche Man2, Roderick W C Scherptong2, Martin J Schalij2, Arie C Maan2, Cees A Swenne2.
Abstract
BACKGROUND: In the prehospital triage of patients presenting with symptoms suggestive of acute myocardial ischemia, reliable myocardial ischemia detection in the electrocardiogram (ECG) is pivotal. Due to large interindividual variability and overlap between ischemic and nonischemic ECG-patterns, incorporation of a previous elective (reference) ECG may improve accuracy. The aim of the current study was to explore the potential value of serial ECG analysis using subtraction electrocardiography.Entities:
Keywords: acute myocardial ischemia; serial electrocardiography; subtraction electrocardiography; vectorcardiogram
Mesh:
Year: 2019 PMID: 31707764 PMCID: PMC7358788 DOI: 10.1111/anec.12722
Source DB: PubMed Journal: Ann Noninvasive Electrocardiol ISSN: 1082-720X Impact factor: 1.468
Subtraction electrocardiography: list of ECG difference descriptors and univariate AUC
| Category | # | Symbol | Unit | Description | AUC |
|---|---|---|---|---|---|
| QRS | 1 | ΔQRSdur | ms | QRS‐duration difference, signed | 0.61 |
| 2 |
| ms | QRS‐duration difference, absolute value | 0.50 | |
| 3 |
| μV | Maximal QRS‐vector magnitude difference, signed | 0.47 | |
| 4 |
| μV | Maximal QRS‐vector magnitude difference, absolute value | 0.55 | |
| 5 |
| mV·ms | QRS‐integral vector magnitude difference, signed | 0.56 | |
| 6 |
| mV·ms | QRS‐integral vector magnitude difference, absolute value | 0.57 | |
| 7 | ΔQRScmplx | QRS‐complexity difference, signed | 0.62 | ||
| 8 |
| QRS‐complexity difference, absolute value | 0.62 | ||
| J | 9 |
| μV | J difference‐vector magnitude | 0.80 |
| 10 | ∑|∆Ji|; 8 leads | μV | Summed absolute values of the differences in J‐point amplitudes, 8 leads | 0.82 | |
| 11 | ∑|∆Ji|; 12 leads | μV | Summed absolute values of the differences in J‐point amplitudes, 12 leads | 0.83 | |
| T | 12 |
| μV | Maximal T‐vector magnitude difference, signed | 0.59 |
| 13 |
| μV | Maximal T‐vector magnitude difference, absolute value | 0.62 | |
| 14 |
| mV·ms | T‐integral vector magnitude difference, signed | 0.58 | |
| 15 |
| mV·ms | T‐integral vector magnitude difference, absolute value | 0.59 | |
| 16 | ΔTcmplx | T‐wave complexity difference, signed | 0.47 | ||
| 17 | |ΔTcmplx| | T‐wave complexity difference, absolute value | 0.55 | ||
| 18 | ΔTsym | T‐wave symmetry difference, signed | 0.46 | ||
| 19 | |ΔTsym| | T‐wave symmetry difference, absolute value | 0.58 | ||
| 20 | Δ# leads with positive T waves | Difference in the number of leads with positive T waves | 0.43 | ||
| 21 | # leads with a T‐wave polarity change | Number of leads with a T‐wave polarity change | 0.62 | ||
| General | 22 | ΔQTinterval | ms | QT‐duration difference, signed | 0.45 |
| 23 | |ΔQTinterval| | ms | QT‐duration difference, absolute value | 0.57 | |
| 24 |
| mV·ms | Ventricular‐gradient difference‐vector magnitude | 0.64 | |
| 25 | ΔSA | QRS‐T spatial‐angle difference, signed | 0.53 | ||
| 26 | |ΔSA| | QRS‐T spatial‐angle difference, absolute value | 0.60 | ||
| 27 | ΔHR | bpm | Heart‐rate difference, signed | 0.55 | |
| 28 | |ΔHR| | bpm | Heart‐rate difference, absolute value | 0.56 | |
| Age & Sex | 29 | Sex | M/F | Sex of the patient, male/female | 0.43 |
| 30 | Age | years | Age of the patient | 0.58 |
Variables used as input for the logistic regression model with corresponding univariate areas‐under‐the‐curve in the overall model.
Abbreviation: AUC, area‐under‐the‐curve.
Significantly > 0.50.
Figure 1Exclusion flowchart. Flowchart illustrating the exclusion steps leading from the patients who satisfied the inclusion criteria (1. urgent transport by the emergency medical services to one of the participating hospitals in the regions Hollands Midden and Amsterdam; 2. and at least one ECG recording was made during the ambulance ride; 3 to include or exclude myocardial ischemia) to the composition of the patient group studied in the here‐described research project. = not usable, † = <7 days before acute event, ‡ = major cardiac event between the recording of the reference ECG and the ambulance ECG, * = categories may overlap. EHR, electronic health record
Demographic and anthropomorphic characteristics of the study group
|
Study group
| ||||||
|---|---|---|---|---|---|---|
| Sex ( | Male/female | (%/%) | 736/689 | 51.6/48.4 | ||
| Age (years) | Median | (min–max) | [Q1–Q3] | 69 | (18–97) | [58–79] |
| Height (cm) | Median | (min–max) | [Q1–Q3] | 171 | (141–198) | [164–178] |
| Weight (kg) | Median | (min–max) | [Q1–Q3] | 79 | (42–170) | [69–90] |
| BMI (kg/m2) | Median | (min–max) | [Q1–Q3] | 26.9 | (16.6–49.1) | [24.3–30.4] |
Demographic and anthropomorphic characteristics of the study group.
Abbreviations: N/n = number of patients, BMI = body mass index, Q1, first interquartile, Q3, third interquartile.
Medical history of the study group
|
| ||
|---|---|---|
| Cardiac disease | 961 | (67.4) |
| Myocardial infarction | 420 | (43.7) |
| CAD without myocardial infarction | 278 | (28.9) |
| Other cardiac disease | 263 | (27.4) |
| TIA/iCVA | 179 | (12.6) |
| Noncoronary or cerebrovascular arterial disease | 158 | (11.1) |
| DVT/Pulmonary embolism | 75 | (5.3) |
| Hypertension | 850 | (59.7) |
| Pulmonary disease | 282 | (19.8) |
| Diabetes mellitus type 2 | 354 | (24.8) |
| Chronic kidney disease | 140 | (9.8) |
| Significant disease, any of above | 1,291 | (90.6) |
| No significant disease | 134 | (9.4) |
Medical history of the study group. The medical history comprises the patients’ health issues and events which are relevant to this study prior to the time of inclusion in the SUBTRACT study (i.e., visit by the EMS).
Abbreviations: CAD, coronary artery disease; CVA, cerebrovascular accident; DVT, deep venous thrombosis; N, number of patients; TIA, transient ischemic attack.
Categories may overlap.
Clinical diagnoses and ischemia classes
|
| totals | presumed ischemic | probably ischemic | uncertain | probably nonischemic | presumed nonischemic |
|---|---|---|---|---|---|---|
| Cardiac | 465(32.6) | 152(91.6) | 24(85.7) | 127(64.8) | 16(76.2) | 146(14.4) |
| Primary myocardial ischemia | 273(19.2) | 134(80.7) | 9(32.1) | 90(45.9) | 2(9.5) | 38(3.7) |
| STEMI | 68(4.8) | 67(40.4) | 1(3.6) | 0(0.0) | 0(0.0) | 0(0.0) |
| NSTEMI | 76(5.3) | 67(40.4) | 8(28.6) | 1(0.5) | 0(0.0) | 0(0.0) |
| UAP | 87(6.1) | 0(0.0) | 0(0.0) | 87(44.4) | 0(0.0) | 0(0.0) |
| Stable angina | 42(2.9) | 0(0.0) | 0(0.0) | 2(1) | 2(9.5) | 38(3.7) |
| Arrhythmia/conduction disturbances | 111(7.8) | 10(6) | 3(10.7) | 15(7.7) | 1(4.8) | 82(8.1) |
| Cardiac decompensation | 74(5.2) | 16(9.6) | 12(42.9) | 25(12.8) | 15(71.4) | 6(0.6) |
| Valvular disease | 22(1.5) | 3(1.8) | 2(7.1) | 11(5.6) | 0(0.0) | 6(0.6) |
| Inflammatory | 17(1.2) | 0(0.0) | 0(0.0) | 1(0.5) | 0(0.0) | 16(1.6) |
| Resuscitation | 12(0.8) | 9(5.4) | 0(0.0) | 3(1.5) | 0(0.0) | 0(0.0) |
| Hypotension/hypertension | 117(8.2) | 4(2.4) | 5(17.9) | 41(20.9) | 1(4.8) | 66(6.5) |
| Noncoronary vessel disease | 36(2.5) | 6(3.6) | 1(3.6) | 8(4.1) | 0(0.0) | 21(2.1) |
| Pulmonary (excl. PE) | 108(7.6) | 6(3.6) | 3(10.7) | 13(6.6) | 1(4.8) | 85(8.4) |
| Gastrointestinal | 161(11.3) | 0(0.0) | 2(7.1) | 3(1.5) | 4(19) | 152(15) |
| Neurology (excl. CVA) | 11(0.8) | 0(0.0) | 0(0.0) | 0(0.0) | 1(4.8) | 10(1) |
| General infectious disease | 32(2.2) | 3(1.8) | 3(10.7) | 13(6.6) | 0(0.0) | 13(1.3) |
| ENT/endocrine/urogenital/gynecology | 22(1.5) | 0(0.0) | 2(7.1) | 2(1) | 1(4.8) | 17(1.7) |
| Dermal/costo/tendo/myogenic | 139(9.8) | 0(0.0) | 0(0.0) | 4(2) | 0(0.0) | 135(13.3) |
| Psychiatry | 61(4.3) | 0(0.0) | 0(0.0) | 3(1.5) | 0(0.0) | 58(5.7) |
| No acute pathology nos | 368(25.8) | 0(0.0) | 0(0.0) | 5(2.6) | 1(4.8) | 362(35.7) |
| Lab abnormalities other than troponin | 23(1.6) | 3(1.8) | 1(3.6) | 11(5.6) | 1(4.8) | 7(0.7) |
| Other | 22(1.5) | 0(0.0) | 0(0.0) | 4(2) | 0(0.0) | 18(1.8) |
| Total | 1,425(100) | 166(100) | 28(100) | 196(100) | 21(100) | 1,014(100) |
For the total study group and stratified by ischemia class, numbers of patients with one (or more) clinical diagnosis in a group with corresponding percentages. The percentages between parentheses relate to the total number of patients in the study group or ischemia class. Of the presumed ischemic patients, 81%/19% had a diagnosis involving primary/secondary myocardial ischemia, as opposed to 32%/68% of the probably ischemic patients. Hence, secondary ischemia was more often causing a probable ischemic classification rather than a presumed ischemic classification.
Abbreviations: CVA, cerebral vascular accident; excl., exclusive of lab abnormalities, laboratory abnormalities; nos, not otherwise specified; NSTEMI, non‐ST‐elevation myocardial infarction; PE, pulmonary embolism; STEMI, ST‐elevation myocardial infarction; UAP, unstable angina pectoris.
No acute pathology, this refers to diagnoses in which no explicit diagnosis is stated, but in which all relevant acute diagnoses have been excluded by the physician.
Clinical characteristics in the five ischemia classes
| Presumed ischemic | Probably ischemic | Uncertain | Probably not ischemic | Presumed nonischemic | |
|---|---|---|---|---|---|
|
Male/female (%/%) |
108/58 (65/35) |
13/15 (46/54) |
112/84 (57/43) |
11/10 (52/48) |
492/522 (49/51) |
|
Median age (years) (min–max) [Q1–Q3] |
70 (34–93) [63–79] |
78 (42–97) [62–89] |
72 (30–95) [63–81] |
75 (48–95) [73–80] |
67 (18–97) [57–78] |
|
Chest pain at ambulance visit (%) |
142 (86) |
17 (61) |
159 (81) |
13 (62) |
801 (79) |
|
History of coronary artery disease (%) |
88 (53) |
17 (61) |
127 (65) |
14 (67) |
452 (45) |
|
Admitted to hospital* (%) |
165 (99) |
26 (93) |
150 (77) |
16 (76) |
409 (40) |
|
Died during or before hospital admission (%) |
11 (7) |
3 (11) |
10 (5) |
0 (0) |
3 (0) |
|
Coronary catheterization (%) |
128 (77) |
9 (32) |
65 (33) |
1 (5) |
44 (4) |
|
Coronary intervention (%) |
116 (70) |
1 (4) |
40 (20) |
1 (5) |
4 (0) |
| Elevated troponin levels according physician positive†/negative/missing‡ (%) | 132/0/34 (80/0/20) | 15/0/13 (54/0/46) | 32/98/66 (16/50/34) | 1/9/11 (5/43/52) | 32/647/335 (3/64/33) |
| Numbers of patients in each ischemia class | 166 | 28 | 196 | 21 | 1,014 |
Demographic data and clinical characteristics of the total study population stratified by ischemia class.
Symbols: * = admission of at least 24 hours or in case or for additional tests, e.g., coronary catheterization, were performed. Patients discharged from the emergency room were not classified as admitted. † = elevated, but in some cases the attending physician attributed the elevation to another factor, e.g., renal failure; ‡ = missing either due to the absence of measurements or no mention of the troponin values in the medical letter.
Figure 2Receiver‐operating‐characteristics of learning and testing. ROCs of the 100 learning and testing realizations. From the plot can be appreciated that the differences with the Uni‐G algorithm in the test sets were statistically not significant